Qube Research & Technologies (QRT)’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-1,093,561
| Closed | -$243M | – | 3481 |
|
|
2025
Q4 | $250M | Sell |
1,093,561
-489,743
| -31% | -$112M | 0.25% | 66 |
|
|
2025
Q3 | $367M | Sell |
1,583,304
-1,830,775
| -54% | -$373M | 0.38% | 38 |
|
|
2025
Q2 | $634M | Buy |
3,414,079
+1,281,601
| +60% | +$238M | 0.64% | 8 |
|
|
2025
Q1 | $447M | Buy |
2,132,478
+1,343,860
| +170% | +$261M | 0.52% | 22 |
|
|
2024
Q4 | $140M | Sell |
788,618
-280,621
| -26% | -$51.6M | 0.18% | 130 |
|
|
2024
Q3 | $211M | Buy |
1,069,239
+328,701
| +44% | +$61.3M | 0.31% | 49 |
|
|
2024
Q2 | $127M | Sell |
740,538
-543,423
| -42% | -$90M | 0.2% | 109 |
|
|
2024
Q1 | $234M | Buy |
1,283,961
+89,165
| +7% | +$15.4M | 0.37% | 39 |
|
|
2023
Q4 | $185M | Buy |
1,194,796
+841,342
| +238% | +$123M | 0.36% | 51 |
|
|
2023
Q3 | $52.7M | Sell |
353,454
-555,882
| -61% | -$81.6M | 0.14% | 189 |
|
|
2023
Q2 | $123M | Buy |
+909,336
| New | +$133M | 0.45% | 44 |
|
|
2023
Q1 | – | Sell |
-118,876
| Closed | -$18.2M | – | 2482 |
|
|
2022
Q4 | $19.2M | Buy |
118,876
+114,346
| +2,524% | +$17.5M | 0.1% | 290 |
|
|
2022
Q3 | $608K | Sell |
4,530
-22,708
| -83% | -$3.26M | ﹤0.01% | 1398 |
|
|
2022
Q2 | $4.17M | Buy |
27,238
+20,238
| +289% | +$3.09M | 0.03% | 558 |
|
|
2022
Q1 | $1.14M | Buy |
+7,000
| New | +$1.02M | 0.01% | 1110 |
|
|
2021
Q4 | – | Sell |
-2,072
| Closed | -$224K | – | 2470 |
|
|
2021
Q3 | $224K | Sell |
2,072
-226,548
| -99% | -$25.9M | ﹤0.01% | 1607 |
|
|
2021
Q2 | $25.8M | Buy |
228,620
+198,619
| +662% | +$22.4M | 0.29% | 56 |
|
|
2021
Q1 | $3.25M | Buy |
+30,001
| New | +$3.21M | 0.05% | 476 |
|
|
2020
Q4 | – | Sell |
-289,815
| Closed | -$25.4M | – | 1754 |
|
|
2020
Q3 | $25.4M | Buy |
289,815
+98,130
| +51% | +$9.24M | 0.36% | 49 |
|
|
2020
Q2 | $18.8M | Buy |
+191,685
| New | +$16.9M | 0.28% | 71 |
|
|
2019
Q2 | – | Sell |
-52,823
| Closed | -$4.26M | – | 389 |
|
|
2019
Q1 | $4.26M | Buy |
52,823
+35,375
| +203% | +$2.89M | 0.56% | 43 |
|
|
2018
Q4 | $1.61M | Sell |
17,448
-9,979
| -36% | -$878K | 0.69% | 15 |
|
|
2018
Q3 | $2.59M | Buy |
27,427
+13,609
| +98% | +$1.29M | 0.34% | 57 |
|
|
2018
Q2 | $1.28M | Buy |
13,818
+10,857
| +367% | +$1.06M | 0.81% | 14 |
|
|
2018
Q1 | $280K | Buy |
+2,961
| New | +$325K | 0.11% | 118 |
|
Other funds holding ABBV
VCM
VPM
Qube Research & Technologies (QRT)'s ABBV Position: Q1 2026 in Review
Qube Research & Technologies (QRT) sold out of AbbVie (ABBV) in Q1 2026, closing a stake of 1,093,561 shares — an estimated $243M sold.
Qube Research & Technologies (QRT) first reported a position in ABBV in Q1 2018 and held it in 25 quarters. The position peaked at $634M in Q2 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Qube Research & Technologies (QRT) reported no remaining AbbVie position as of Q1 2026 after selling out during the quarter.
- Qube Research & Technologies (QRT) sold 1,093,561 AbbVie shares in Q1 2026, an estimated $243M.
- Qube Research & Technologies (QRT) first reported a position in AbbVie in Q1 2018 and held it in 25 quarters.
- Qube Research & Technologies (QRT)'s AbbVie position peaked at $634M in Q2 2025.
- 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.